DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Sweden
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
ACOU logo

AcouSort AB (publ) Stock Price

OM:ACOU Community·SEK 58.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

ACOU Share Price Performance

SEK 2.78
-0.47 (-14.46%)
​
SEK 2.78
-0.47 (-14.46%)
​
Price SEK 2.78
Fri, 11 Sep 26
Share Pricen/a

ACOU Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and fair value.

3 Risks
2 Rewards
View Full Analysis

AcouSort AB (publ) Key Details

SEK 9.3m

Revenue

SEK 252.0k

Cost of Revenue

SEK 9.1m

Gross Profit

SEK 20.3m

Other Expenses

-SEK 11.2m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-0.53
97.29%
-120.49%
0%
View Full Analysis

About ACOU

Founded
2010
Employees
11
CEO
Torsten Freltoft
WebsiteView website
www.acousort.com

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, a module that enables in-line analysis of blood plasma from whole blood samples; Acoustic Separation Module, a microfluidic solution that provides continuous separation, washing or up-concentration of cells; Acoustic Trapping Module, a microfluidic cell sorters or quality control systems for bioreactors and cell therapy production; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has a collaboration agreement with Moeller Medical to exhibit a prototype system for analyzing separation of cells from body fluids. AcouSort AB (publ) was incorporated in 2010 and is based in Lund, Sweden.

Recent ACOU News & Updates

Recent updates

No updates

AcouSort AB (publ) Competitors

GENO logo

Genovis AB (publ.)

Symbol: OM:GENO
Market cap: SEK 1.4b
ALZCUR logo

AlzeCure Pharma

Symbol: OM:ALZCUR
Market cap: SEK 1.2b
MVIR logo

Medivir

Symbol: OM:MVIR
Market cap: SEK 1.1b
SYNACT logo

SynAct Pharma

Symbol: OM:SYNACT
Market cap: SEK 1.1b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide